Regxia Inc. is a scientific and regulatory consulting firm catering to the pharmaceutical and biotech industries. The company offers personalized attention to address specific regulatory needs, with a focus on providing a full range of regulatory services to support products at all stages of development. Regxia excels in delivering high-quality, customized solutions consistent with the ever-evolving regulatory environment. With a strong understanding of global regulatory requirements, the company outlines appropriate regulatory strategies to minimize time to market. Founded in 2007 and headquartered in Canada, Regxia's team provides diverse regulatory services, including scientific writing, strategic consulting, dossier publishing, CMC, clinical, and post-approval support. The company's dedication to client success is evident through its innovative approaches in the industry, aiming to ensure clients’ regulatory objectives are achieved. With a focus on Proven Experience...Fresh Thinking, Regxia is committed to using its knowledge, experience, and insight to support its clients' success in the pharmaceutical and biotech sectors. For more information, visit www.regxia.com or contact [email protected].
There is no investment information
No recent news or press coverage available for Regxia Inc..